Abstract
DsRNAs longer than 30bp induce interferon response and global changes in gene expression profile in mammalians. 21bp siRNA and 25/27bp dsiRNA acting via RNA interference mechanism are used for specific gene silencing in this class of organisms. We designed selectively 2'-O-methyl-modified 42 and 63bp anti-MDR1-siRNAs that silence the expression of P-glycoprotein and restore the sensitivity of drug-resistant cancer cells to cytostatic more efficiently than canonical 21bp siRNAs. We also show that they act in a Dicer-independent mode and are devoid of immunostimulating properties. Our findings suggest that 42 and 63bp siRNAs could be used as potential therapeutics.
Keywords:
2′-O-methyl modification; Dicer-substrate RNAs; Interferon response; small interfering RNA.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Drug Resistance, Neoplasm*
-
Gene Expression
-
Gene Knockdown Techniques
-
Humans
-
RNA Interference*
-
RNA Processing, Post-Transcriptional
-
RNA, Small Interfering / chemistry
-
RNA, Small Interfering / genetics*
-
RNA, Small Interfering / metabolism
-
Ribose / analogs & derivatives
-
Ribose / chemistry
-
Vinblastine / pharmacology
Substances
-
ABCB1 protein, human
-
ATP Binding Cassette Transporter, Subfamily B
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Antineoplastic Agents, Phytogenic
-
RNA, Small Interfering
-
D-2-O-methylribose
-
Vinblastine
-
Ribose